Decreased plasma tryptophan in pregnancy

被引:123
作者
Schrocksnadel, H
BaierBitterlich, G
Dapunt, O
Wachter, H
Fuchs, D
机构
[1] UNIV INNSBRUCK, INST MED CHEM & BIOCHEM, A-6020 INNSBRUCK, AUSTRIA
[2] LUDWIG BOLTZMANN INST AIDS RES, INNSBRUCK, AUSTRIA
关键词
D O I
10.1016/0029-7844(96)00084-1
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To examine levels of serum tryptophan and its degradation product kynurenine in uncomplicated pregnancy, according to the week of pregnancy and the concentrations of neopterin. Methods: Plasma was analyzed from 45 healthy pregnant women (15 in each trimester), 15 healthy puerperas, and 20 nonpregnant controls. Tryptophan and kynurenine were measured by reverse-phase, high-performance liquid chromatography, and neopterin by radioimmunoassay. Results: In healthy pregnant women, tryptophan values decreased (median first trimester: 72 mu mol/L; second trimester: 51 mu mol/L; third trimester: 46 mu mol/L; P < .001) in a manner correlated with the duration of pregnancy (Spearman rank correlation coefficient r(s) = -0.771, P < .001) and normalized in the puerperium (median 60 mu mol/L). No change in kynurenine, a tryptophan degradation product, was observed, but the ratio of kynurenine to tryptophan increased during pregnancy and correlated positively with gestational age (r(s) = 0.714, P < .001). In addition, an inverse correlation existed between neopterin and tryptophan concentrations (r(s) = -0.566, P < .001), as well as a positive one between neopterin and the kynurenine to tryptophan ratio (r(s) = 0.660, P < .001). Conclusion: Tryptophan levels decrease during normal pregnancy and the decrease may be related to immune activation phenomena.
引用
收藏
页码:47 / 50
页数:4
相关论文
共 22 条
[1]  
BROWN RR, 1989, CANCER RES, V49, P4941
[2]   INDUCTION OF TRYPTOPHAN DEGRADATION INVITRO AND INVIVO - A GAMMA-INTERFERON-STIMULATED ACTIVITY [J].
BYRNE, GI ;
LEHMANN, LK ;
KIRSCHBAUM, JG ;
BORDEN, EC ;
LEE, CM ;
BROWN, RR .
JOURNAL OF INTERFERON RESEARCH, 1986, 6 (04) :389-396
[3]   THE PROGNOSTIC VALUE OF CELLULAR AND SEROLOGIC MARKERS IN INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 [J].
FAHEY, JL ;
TAYLOR, JMG ;
DETELS, R ;
HOFMANN, B ;
MELMED, R ;
NISHANIAN, P ;
GIORGI, JV .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (03) :166-172
[4]   BRAIN-SEROTONIN CONTENT - PHYSIOLOGICAL REGULATION BY PLASMA NEUTRAL AMINO-ACIDS [J].
FERNSTROM, JD ;
WURTMAN, RJ .
SCIENCE, 1972, 178 (4059) :414-+
[5]   KYNURENINE METABOLITES OF TRYPTOPHAN - IMPLICATIONS FOR NEUROLOGIC DISEASES [J].
FREESE, A ;
SWARTZ, KJ ;
DURING, MJ ;
MARTIN, JB .
NEUROLOGY, 1990, 40 (04) :691-695
[6]   ENDOGENOUS RELEASE OF INTERFERON-GAMMA AND DIMINISHED RESPONSE OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS TO ANTIGENIC-STIMULATION [J].
FUCHS, D ;
MALKOVSKY, M ;
REIBNEGGER, G ;
WERNER, ER ;
FORNI, G ;
WACHTER, H .
IMMUNOLOGY LETTERS, 1989, 23 (02) :103-108
[7]  
FUCHS D, 1990, J ACQ IMMUN DEF SYND, V3, P873
[8]   NEOPTERIN AS A MARKER FOR ACTIVATED CELL-MEDIATED-IMMUNITY - APPLICATION IN HIV INFECTION [J].
FUCHS, D ;
HAUSEN, A ;
REIBNEGGER, G ;
WERNER, ER ;
DIERICH, MP ;
WACHTER, H .
IMMUNOLOGY TODAY, 1988, 9 (05) :150-155
[9]  
FUCHS D, 1993, HIV 1 INFECT CENTRAL, P103
[10]  
FUCHS D, IN PRESS RECENT ADV